Loading clinical trials...
Loading clinical trials...
This study will evaluate the response rate to treatment with pentostatin in steroid-refractory acute graft versus host disease.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Ohio State University Comprehensive Cancer Center
NCT03148743 · Acute-graft-versus-host Disease
NCT07070674 · Acute Graft-versus-Host Disease
NCT00001529 · Graft-Versus-Host Disease, Graft-versus-leukemia, and more
NCT06910969 · Bone Marrow Transplant Complications, Graft-versus-Host Disease
NCT06660355 · Chronic Graft-versus-host Disease (cGVHD)
Ohio State University
Columbus, Ohio
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions